FSME-IMMUN CC susp inj aiguille sép ser pré 0.5 ml

7680004500039 CH-450 J07BA01 08.08.
FSME-IMMUN CC susp inj aiguille sép ser pré 0.5 ml
FSME-IMMUN CC susp inj aiguille sép ser pré 0.5 ml
FSME-IMMUN CC susp inj aiguille sép ser pré 0.5 ml
1 / 3
google

Details

Product number
0045002
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
virus FSME inactivatus (Stamm Neudörfl) 2.4 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.35 mg, albuminum seri humani, natrii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.42 mg et kalium 0.013 mg, residui: saccharum, formaldehydum, protamini sulfas, neomycinum, gentamicinum.

Articles (1)

FSME-Immun CC, Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
06/08/2024
Professional SmPC
Français
06/08/2024
Professional SmPC
Italien
06/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
2.4 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.35 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.42 MG Substance HBESI
(N/A)
0.013 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 45.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2017

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
450
Drug name
FSME-Immun CC, Injektionssuspension in einer Fertigspritze
Galenic form
SUPA
ATC Code
J07BA01
Authorization status
Z
Dispensation category
B
First authorization
06/08/1979
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Frühsommer-Meningoenzephalitis, ab dem vollendeten 16. Lebensjahr

Packaging details

Description (FR)
FSME-IMMUN CC susp inj aiguille sép ser pré 0.5 ml
Description (DE)
FSME-IMMUN CC Inj Susp sep Nadel Fertspr 0.5 ml
Market launch
05/11/2001
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

FSME-IMMUN CC susp inj s aiguil 10 ser pré 0.5 ml
10 FESP
View